Article
Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia.
Journal of neurology, neurosurgery, and psychiatry - 1 Mar 2020
Heller Carolin, Foiani Martha S, Moore Katrina, Convery Rhian, Bocchetta Martina, Neason Mollie, Cash David M, Thomas David, Greaves Caroline V, Woollacott Ione Oc, Shafei Rachelle, Van Swieten John C, Moreno Fermin, Sanchez-Valle Raquel, Borroni Barbara, Laforce Robert, Masellis Mario, Tartaglia Maria Carmela, Graff Caroline, Galimberti Daniela, Rowe James B, Finger Elizabeth, Synofzik Matthis, Vandenberghe Rik, de Mendonca Alexandre, Tagliavini Fabrizio, Santana Isabel, Ducharme Simon, Butler Christopher R, Gerhard Alex, Levin Johannes, Danek Adrian, Frisoni Giovanni, Sorbi Sandro, Otto Markus, Heslegrave Amanda J, Zetterberg Henrik, Rohrer Jonathan D
Abstract excerpt
BACKGROUND: There are few validated fluid biomarkers in frontotemporal dementia (FTD). Glial fibrillary acidic protein (GFAP) is a measure of astrogliosis, a known pathological process of FTD, but has yet to be explored as potential biomarker. METHODS: Plasma GFAP and neurofilament light chain (NfL) concentration were measured in 469 individuals enrolled in the Genetic FTD Initiative: 114 C9orf72 expansion...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.